Teleflex (TFX) β†’ Stock, financial statements
Advertising

Teleflex

178.16 USD +2.20 (+0.65%)
Dec 20 πŸ‡ΊπŸ‡Έ NYSE TFX
Dividends
Favorites
  • TFX Ticker
  • πŸ‡ΊπŸ‡Έ NYSE Exchange
  • 15,200 Employees
2 rated
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon

Financial statements β€” Teleflex

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
20 ← 16 2020 2019 2018 2017 2016
Total Revenue
2.5B 2.6B 2.4B 2.1B 1.9B
Cost Of Revenue
1.2B 1.1B 1.1B 970M 870M
Gross Profit
1.3B 1.5B 1.4B 1.2B 1M
Research and Development
120M 110M 110M 85M 59M
Selling General and Admin
740M 930M 880M 700M 560M
Operating Expense
2.1B 2.2B 2B 1.8B 1.5B
Operating Income
460M 440M 400M 390M 370M
Other Income Expense Net
0 0 0 0 0
EBIT
460M 440M 400M 390M 370M
Interest Income
65M 79M 100M 82M 54M
Pretax Income
360M 340M 220M 280M 250M
Income Tax
22M -120M 23M 130M 8.1M
Minority Interest
0 0 0 0 460K
Net Income
340M 460M 200M 150M 240M
Net Income Basic
340M 460M 200M 150M 240M
20 ← 16 2020 2019 2018 2017 2016
Current cash
380M 300M 360M 330M 540M
Short term investments
140M 110M 85M 54M 49M
Receivables
400M 420M 370M 350M 270M
Inventory
510M 480M 430M 400M 320M
Other current assets
140M 110M 85M 54M 49M
Current assets
1.4B 1.3B 1.2B 1.1B 1.2B
Long term investments
5.7B 5B 5B 5.1B 2.7B
Property plant equipment
470M 430M 430M 380M 300M
Goodwill
2.6B 2.2B 2.2B 2.2B 1.3B
Intangible assets
2.5B 2.2B 2.3B 2.4B 1.1B
Other assets
42M 52M 35M 47M 35M
Total assets
7.2B 6.3B 6.3B 6.2B 3.9B
Accounts payable
100M 100M 110M 92M 69M
Current long term debt
100M 50M 87M 87M 180M
Other current liabilities
340M 410M 390M 310M 180M
Total current liabilities
540M 560M 580M 480M 430M
Long term debt
2.4B 1.9B 2.1B 2.2B 850M
Other liabilities
330M 370M 480M 500M 200M
Minority Interest
0 0 0 0 0
Total Liabilities
3.8B 3.3B 3.7B 3.8B 1.8B
Common stock
46M 46M 46M 45M 43M
Retained earning
3.1B 2.8B 2.4B 2.3B 2.2B
Treasury stock
-160M -170M -170M -230M -170M
Capital surplus
β€’ β€’ β€’ β€’ β€’
Shareholder equity
3.3B 3B 2.5B 2.4B 2.1B
Net tangible assets
-1.8B -1.4B -2B -2.2B -230M
20 ← 16 2020 2019 2018 2017 2016
Net Income
340M 460M 200M 150M 240M
Depreciation
230M 210M 210M 160M 120M
Changes in receivables
-24M 52M 20M 74M 9.6M
Changes in inventories
37M 49M 32M 80M -14M
Cash change
75M -56M 24M -210M 210M
Cash flow
440M 440M 440M -6.4M 410M
Capital expenditures
-91M -100M -81M -71M -53M
Investments
β€’ β€’ β€’ β€’ β€’
Investing activity other
β€’ β€’ β€’ β€’ β€’
Total investing cash flows
-840M -73M -200M -1.8B -57M
Dividends paid
β€’ β€’ β€’ β€’ β€’
Net borrowings
2B 1.5B 1.7B 1.9B 440M
Other financing cash flows
β€’ β€’ β€’ β€’ β€’
Cash flow financing
460M -420M -210M 1.1B -120M
Exchange rate effect
β€’ β€’ β€’ β€’ β€’

Teleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates through the following business segments: Vascular North America, Interventional North America, Anesthesia North America, Surgical North America, Europe, the Middle East and Africa (EMEA), Asia and Original Equipment Manufacturer and Development Services (OEM). The Vascular North America segment products facilitate a variety of critical care therapies, including the administration of intravenous medications and other therapies and the measurement of blood pressure and taking of blood samples through a single puncture site. The Interventional North America segment is comprised of the North American component of Vascular Solutions business. The Anesthesia North America segment provides products for clinicians working primarily in emergency rooms, surgery and critical care settings. The Surgical North America segment products are predominantly comprised of single-use products, including ligation clips and closure products; appliers and sutures used in a variety of surgical procedures; access ports used in minimally invasive laparoscopic surgical procedures, including robotic surgery, and fluid management products used for chest drainage. The EMEA segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves two end markets: hospitals and healthcare providers, and home health. The Asia segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. Teleflex was founded in 1943 and is headquartered in Wayne, PA.